October 31, 2014

Bruker Opens Asia’s First Preclinical Imaging Centre in A*STAR’s Singapore Bioimaging Consortium (SBIC)

SBIC-Bruker-PCI-Center-Opening

(From left to right) Mr Lim Chuan Poh, Chairman of A*STAR, A*STAR’s SBIC Executive Director, Prof Patrick J. Cozzone and President of Bruker BioSpin’s Preclinical Imaging Division, Dr Wulf I. Jung

SINGAPORE, October 31, 2014 – Bruker Corporation, the leading manufacturer of scientific instruments for molecular research, today opened its Preclinical Imaging (PCI)  Centre in collaboration with the Singapore Bioimaging Consortium (SBIC), a research institute under the Agency for Science, Technology and Research (A*STAR). Located within SBIC’s premises at Biopolis, the SBIC-Bruker PCI centre is the first facility of its kind in Asia. The new SBIC-Bruker PCI centre will provide demonstration, training and applications support for Bruker’s preclinical portfolio and multi-modal imaging platforms.

Through the new SBIC-Bruker PCI Centre, A*STAR’s research institutions will be able to leverage Bruker’s advanced imaging platforms to boost their research efforts while the company can tap on SBIC’s talent and imaging capabilities. Besides gaining access to SBIC’s talent and imaging expertise, the SBIC-Bruker PCI Centre will allow Bruker to foster closer collaborations with SBIC’s partners such as those in the clinical and academic community, as well as the pharmaceutical companies with research operations in Singapore.

Dr. Wulf I. Jung, President of Bruker BioSpin’s Preclinical Imaging Division, explained: “At Bruker we are extremely proud to be opening our new Preclinical Imaging Centre of Excellence in Singapore. With differentiated, high performance products we enable novel preclinical imaging research and applications and gain access to new markets, while maintaining our excellent reputation in the scientific research community. To celebrate, we have organized a workshop for all those in preclinical imaging in the region including leading researchers.”

For more information on Bruker's preclinical imaging solution please visit www.preclinicalimaging.com. 

Media Contact:   
Dr. Thorsten Thiel
Bruker Director of Marketing Communications
T: +49 (721) 5161–6500   
E: thorsten.thiel@bruker.com